SLNO Operating Cash Flow Growth
Soleno Therapeutics Inc · Operating Cash Flow Growth
SLNO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported179.32%period ending
SLNO Quarterly Cash from Operations YoY % (-124.43% → 179.32%)
Year-over-year change
High-resolution chart · PNG
SLNO operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 179.3234% | |
| 303.0095% | |
| 392.3221% | |
| 28.5706% | |
| -161.4304% | |
| -279.9652% | |
| -135.7233% | |
| -217.1218% | |
| -86.2069% | |
| -22.7688% | |
| -35.9966% | |
| -20.4762% | |
| -5.7529% | |
| 25.0619% | |
| 13.8735% | |
| 42.3437% | |
| 15.0374% | |
| 0.0582% | |
| 12.2972% | |
| -22.6354% | |
| -32.3202% | |
| -35.2837% | |
| -30.6209% | |
| -67.8397% | |
| -53.4852% | |
| -35.8672% | |
| -76.2794% | |
| -41.5636% | |
| -46.3095% | |
| -36.7517% | |
| -17.8776% | |
| 0.5065% | |
| -15.4375% | |
| -1.6361% | |
| 18.4853% | |
| 31.5842% | |
| 45.2058% | |
| 20.4347% | |
| 2.6215% | |
| -79.4758% | |
| -120.2322% | |
| -117.0658% | |
| -126.6623% | |
| -94.654% | |
| -255.1523% | |
| -115.4975% | |
| -36.5923% | |
| 12.6452% | |
| -124.4309% |